Cochrane · systematic review · CD009982

Impact of Haemophilus influenzae type B (Hib) and viral influenza vaccinations in pregnancy for improving maternal, neonatal and infant health outcomes

Salam, RA, Das, JK, Dojo Soeandy, C, et al. · Cochrane Database of Systematic Reviews · 2015 · Cochrane Library

Pregnancy and ChildbirthAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
7
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 5 · 71.4%High 2 · 28.6%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Viral influenza vaccine compared with control in pregnancy for improving maternal, neonatal and infant health outcomes

Population: Pregnant women aged 18 to 38 years and an estimated gestation of 20 to 36 weeks.
7 questions
OutcomeEffectEvidenceStatus / GRADE
Maternal death
Viral influenza vaccine vs control
RR 4.96 [0.24, 103.24]1 study · 2116 participantsModerate
Downgraded: imprecision
Infant death (up to 175 days)
Viral influenza vaccine vs control
RR 0.71 [0.37, 1.37]1 study · 2049 participantsModerate
Downgraded: imprecision
Perinatal death (stillbirth + death in first week of life)
Viral influenza vaccine vs control
RR 1.32 [0.73, 2.38]1 study · 2083 participantsModerate
Downgraded: imprecision
Any respiratory illness in women
Viral influenza vaccine vs control
RR 0.97 [0.91, 1.04]1 study · 2116 participantsHigh
Any respiratory illness in infants
Viral influenza vaccine vs control
RR 1.01 [0.95, 1.07]1 study · 2049 participantsHigh
Maternal hospitalisation for any infection
Viral influenza vaccine vs control
RR 2.27 [0.94, 5.49]1 study · 2116 participantsModerate
Downgraded: imprecision
Neonatal hospitalisation due to sepsis within 28 days of birth
Viral influenza vaccine vs control
RR 1.6 [0.73, 3.5]1 study · 2049 participantsModerate
Downgraded: imprecision